TPTF is a technology-driven venture capital fund, investing in innovative companies shaping the future of global business.

We are an innovation-driven, added value investment partner

The cornerstone of every great company is great people

Innovations that change the world

At TPTF we believe the cornerstone of every great company is great people

The Trans-Pacific Technology Fund (TPTF) is a technology-driven venture capital fund, investing in innovation companies shaping the future of global business We work actively with the leadership of our portfolio companies from different region of the world, supporting their growth At TPTF we believe the cornerstone of every great company is great people Through our extensive network of collaborative partners around the world, we have a global investment scope, seeking to invest in companies across Asia, North America and Europe

We are partnering with the most reputable research powerhouses worldwide and other honored but private investors

Spencer Karrington is an Analyst at TPTF participating in due diligence and researching potential investment opportunities, focusing on digital health, medical and biotech companies in the United States and Southeast Asia Previously, Spencer interned at TPTF and was also the Founder & President of the St Andrews Venture Capital Club He is completing his International Political Economy Honours degree at the University of St Andrews

Executive Yuan Announced to Invest in TPTF via National Development Fund

Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company

MegaPro Gets Listed on the Taiwan Emerging Market Board on October 19

Indonesia-based Rey Assurance launches its holistic approach to insurance with $1M in funding

Finch Therapeutics Announces $90 Million Financing to Advance Pipeline of Investigational Oral Microbiome Drugs